Legend Biotech CorpNASDAQ:LEGN
- LAST PRICE41.2600
- TODAY'S CHANGE (%)-0.2400 (-0.5783%)
- Bid / Lots41.2200/ 1
- Ask / Lots41.3100/ 4
- Open / Previous Close41.5800 / 41.5000
- Day Range
- 52 Week Range
- Volume271,638
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEGN |
|---|---|---|
| 09:32 ET | 2239 | 41.58 |
| 09:34 ET | 200 | 41.24 |
| 09:39 ET | 200 | 41.155 |
| 09:41 ET | 400 | 41.25 |
| 09:43 ET | 770 | 41.24 |
| 09:48 ET | 498 | 41.08 |
| 09:52 ET | 276 | 41.06 |
| 09:54 ET | 35000 | 41.135 |
| 09:57 ET | 2335 | 40.965 |
| 09:59 ET | 300 | 40.92 |
| 10:01 ET | 1374 | 40.815 |
| 10:06 ET | 400 | 40.54 |
| 10:08 ET | 200 | 40.73 |
| 10:10 ET | 1400 | 40.9 |
| 10:12 ET | 1900 | 40.9161 |
| 10:14 ET | 3097 | 41.02 |
| 10:15 ET | 8370 | 41.02 |
| 10:17 ET | 525 | 41.015 |
| 10:19 ET | 900 | 41.11 |
| 10:21 ET | 400 | 41.135 |
| 10:24 ET | 100 | 41.185 |
| 10:26 ET | 300 | 41.19 |
| 10:28 ET | 4215 | 41.03 |
| 10:30 ET | 1000 | 40.99 |
| 10:32 ET | 700 | 41.07 |
| 10:35 ET | 700 | 41.045 |
| 10:37 ET | 100 | 41.12 |
| 10:39 ET | 500 | 41.085 |
| 10:42 ET | 100 | 41.01 |
| 10:44 ET | 200 | 41.075 |
| 10:46 ET | 1600 | 40.965 |
| 10:48 ET | 1560 | 41.02 |
| 10:50 ET | 221 | 41.075 |
| 10:51 ET | 300 | 41.04 |
| 10:53 ET | 1210 | 41.09 |
| 10:55 ET | 2280 | 41.21 |
| 10:57 ET | 900 | 41.28 |
| 11:00 ET | 1500 | 41.355 |
| 11:02 ET | 1300 | 41.31 |
| 11:06 ET | 913 | 41.23 |
| 11:09 ET | 1282 | 41.26 |
| 11:13 ET | 388 | 41.255 |
| 11:15 ET | 6815 | 41.35 |
| 11:18 ET | 3970 | 41.28 |
| 11:20 ET | 1384 | 41.23 |
| 11:22 ET | 1794 | 41.12 |
| 11:24 ET | 700 | 41.195 |
| 11:26 ET | 100 | 41.195 |
| 11:27 ET | 100 | 41.22 |
| 11:29 ET | 2500 | 41.265 |
| 11:31 ET | 2155 | 41.25 |
| 11:33 ET | 200 | 41.25 |
| 11:36 ET | 500 | 41.24 |
| 11:38 ET | 200 | 41.25 |
| 11:40 ET | 1050 | 41.27 |
| 11:42 ET | 1025 | 41.29 |
| 11:44 ET | 800 | 41.235 |
| 11:49 ET | 100 | 41.26 |
| 11:51 ET | 2000 | 41.14 |
| 11:54 ET | 1000 | 41.18 |
| 11:58 ET | 2317 | 41.1075 |
| 12:00 ET | 300 | 41.15 |
| 12:02 ET | 500 | 41.135 |
| 12:03 ET | 100 | 41.145 |
| 12:05 ET | 300 | 41.15 |
| 12:07 ET | 303 | 41.16 |
| 12:09 ET | 1600 | 41.15 |
| 12:12 ET | 300 | 41.16 |
| 12:14 ET | 2100 | 41.105 |
| 12:16 ET | 2991 | 41.17 |
| 12:18 ET | 700 | 41.28 |
| 12:20 ET | 600 | 41.27 |
| 12:21 ET | 2500 | 41.33 |
| 12:23 ET | 200 | 41.34 |
| 12:25 ET | 2627 | 41.42 |
| 12:27 ET | 500 | 41.45 |
| 12:30 ET | 100 | 41.465 |
| 12:32 ET | 2545 | 41.285 |
| 12:34 ET | 50323 | 41.2575 |
| 12:36 ET | 3649 | 41.405 |
| 12:38 ET | 500 | 41.4125 |
| 12:39 ET | 1650 | 41.345 |
| 12:41 ET | 600 | 41.28 |
| 12:43 ET | 500 | 41.21 |
| 12:45 ET | 600 | 41.11 |
| 12:48 ET | 200 | 41.13 |
| 12:50 ET | 1215 | 41.18 |
| 12:52 ET | 1012 | 41.19 |
| 12:54 ET | 2923 | 41.31 |
| 12:56 ET | 13459 | 41.22 |
| 12:57 ET | 2213 | 41.31 |
| 12:59 ET | 2000 | 41.27 |
| 01:01 ET | 100 | 41.3 |
| 01:03 ET | 2329 | 41.25 |
| 01:06 ET | 200 | 41.22 |
| 01:08 ET | 100 | 41.24 |
| 01:10 ET | 200 | 41.24 |
| 01:12 ET | 400 | 41.25 |
| 01:14 ET | 797 | 41.26 |
Yesterday
DJ Legend Biotech Price Target Maintained With a $90.00/Share by Piper Sandler, from 1:22PM ET on Monday Jun 17, 2024 by Dow Jones
1:22PM ET on Monday Jun 17, 2024 by Dow JonesDJ Legend Biotech Initiated at Buy by Truist Securities, from 6:52AM ET on Monday Jun 17, 2024 by Dow Jones
6:52AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 6, 2024
DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 7:04AM ET on Thursday Jun 06, 2024 by Dow Jones
7:04AM ET on Thursday Jun 06, 2024 by Dow Jones
Jun 4, 2024
DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 6:36AM ET on Tuesday Jun 04, 2024 by Dow Jones
6:36AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Legend Biotech Corp | 7.6B | -15.8x | --- |
Ascendis Pharma A/S | 7.3B | -13.1x | --- |
Blueprint Medicines Corp | 6.5B | -21.7x | --- |
Intra-Cellular Therapies Inc | 7.3B | -67.2x | --- |
Cerevel Therapeutics Holdings Inc | 7.6B | -15.4x | --- |
Vaxcyte Inc | 7.8B | -17.1x | --- |
Company Information
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Contact Information
- Headquarters
- 2101 Cottontail LaneSOMERSET, NJ, United States 08873
- Phone
- 732-317-5050
- Fax
- ---
Executives
- Chairman of the Board
- Fangliang Zhang
- Chief Executive Officer, Director
- Ying Huang
- Chief Financial Officer
- Lori Macomber
- Director
- Ye Wang
- Director
- Li Zhu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.6B |
|---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -15.8x |
Price/Sales (TTM) | 22.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
